SAN ANTONIO, Texas, December 03, 2025--bioAffinity Technologies will present case studies at NLCRT in which CyPath® Lung ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Expanded lung cancer screening and smoking cessation programs could prevent tens of thousands of deaths, but systemic barriers and outdated criteria leave high-risk communities behind.

For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival.

November is Lung Cancer Awareness Month. Lung cancer is the leading cause of cancer deaths for both men and women. Smokers ...

L&T Technology Services has announced the development of a next-generation AI-powered platform for respiratory diagnostics and lung navigation. It will be debuted at RSNA 2025.

Under current screening guidelines, almost two-thirds of Americans with lung cancer would not have qualified for required scans, researchers said.

A female AEW star recently shared a heartbreaking social media post revealing her lung cancer diagnosis. Now, the star has ...